MarketFriction

Standard Medical & Pharmaceuticals Ltd

BSE 511042
Market cap₹Cr.
Not trading

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017
Sales0.000.000.000.000.000.000.000.000.000.000.000.00
Expenses0.010.020.030.010.000.000.060.000.020.000.010.00
Operating Profit-0.01-0.02-0.03-0.010.000.00-0.060.00-0.020.00-0.010.00
OPM %
Other Income0.020.050.000.000.000.030.000.000.000.000.000.00
Interest0.000.000.000.000.000.000.000.000.000.000.000.00
Depreciation0.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax0.010.03-0.03-0.010.000.03-0.060.00-0.020.00-0.010.00
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit0.010.03-0.03-0.010.000.03-0.060.00-0.020.00-0.010.00
EPS in Rs
Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017TTM
Sales0.000.000.000.000.000.000.000.000.000.000.000.00
Expenses0.270.410.140.150.160.180.150.130.130.060.030.03
Operating Profit-0.27-0.41-0.14-0.15-0.16-0.18-0.15-0.13-0.13-0.06-0.03-0.03
OPM %
Other Income0.302.690.030.03-0.110.110.040.02-1.360.050.030.00
Interest0.000.000.000.000.000.000.000.000.000.000.000.00
Depreciation0.020.010.010.010.010.010.010.010.000.000.000.00
Profit before tax0.012.27-0.12-0.13-0.28-0.08-0.12-0.12-1.49-0.010.00-0.03
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit0.012.27-0.12-0.13-0.28-0.07-0.11-0.12-1.50-0.010.00-0.03
EPS in Rs
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%%%%
Compounded Profit Growth%%%100%
Stock Price CAGR%%%%
Return on Equity%%%%
Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017
Equity Capital10.8110.8110.8110.8110.8110.8110.8110.8110.8110.8110.8510.85
Reserves-28.46-28.45-26.18-26.30-26.43-26.71-26.78-26.90-27.02-28.51-28.52-28.52
Borrowings9.869.867.377.658.3017.9418.0618.2418.5417.5417.4917.49
Other Liabilities10.9510.9010.8710.6910.570.790.730.640.450.170.190.19
Total Liabilities3.163.122.872.853.252.832.822.792.780.010.010.01
Fixed Assets0.080.060.050.040.040.030.020.020.010.010.010.01
CWIP0.000.000.000.000.000.000.000.000.000.000.000.00
Investments2.752.752.752.752.752.752.752.752.750.000.000.00
Other Assets0.330.310.070.060.460.050.050.020.020.000.000.00
Total Assets3.163.122.872.853.252.832.822.792.780.010.010.01
Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017
Cash from Operating Activity0.560.002.49-0.29-0.25-0.38-0.11-0.18-0.29-0.370.010.00
Cash from Investing Activity0.000.000.000.000.000.000.000.000.001.380.000.00
Cash from Financing Activity-0.560.00-2.490.280.65-0.030.110.180.29-1.00-0.010.00
Net Cash Flow0.000.000.00-0.010.40-0.410.000.000.000.000.000.00
Free Cash Flow0.560.002.49-0.29-0.25-0.38-0.11-0.18-0.29-0.370.010.00
CFO/OP-57%0%-607%207%167%238%61%120%223%285%-17%0%
Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017
Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE %-3.87%-5.66%-5.36%-10.14%
Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018
Promoters5.87%5.87%5.87%5.87%5.87%5.87%5.87%5.87%
DIIs10.82%10.82%10.82%10.82%10.82%10.82%10.82%10.82%
Public83.31%83.31%83.31%83.31%83.31%83.31%83.31%83.31%
No. of Shareholders35,15135,15135,14935,14935,14935,14735,14535,145

Fundamentals

Market Cap₹ Cr.
Current Price₹
Book Value₹
ROCE%
ROE%
Dividend Yield%
Face Value₹ 10.0
Compounded Sales Growth (TTM)%
Compounded Profit Growth (TTM)100%
Standalone figures.
Profitability
ROE, 3-year average4.45%
ROCE, 3-year average-137.33%
ROA, 3-year average-103.76%
ROE, 5-year average2.58%
ROCE, 5-year average-49.45%
ROA, 5-year average-53.94%
Other income / net worth-0.17%
Per share
EPS (TTM)Rs -0.06
EPS (latest quarter)Rs -0.01
EPS, 3-year averageRs -0.70
EPS, 5-year averageRs -0.40
Book value per shareRs -16.29
Free cash flow per shareRs 0.00
Leverage
Total debtRs 17 Cr
Net debtRs 17 Cr
Debt to equity-0.99x
Owners' fund to total sources-176700.00%
Debt to assets174900.00%
Cash flow
Free cash flow (latest year)Rs 0 Cr
FCFE (approx.: FCF + change in debt)Rs 0 Cr
Statement figures
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs -0 Cr
PBDT (TTM)Rs -0 Cr
Profit before tax (TTM)Rs -0 Cr
Net profit (TTM)Rs -0 Cr
Net profit (latest quarter)Rs -0 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total income (latest year)Rs 0 Cr
Share capitalRs 11 Cr
ReservesRs -29 Cr
Shareholders' fundsRs -18 Cr
Total assetsRs 0 Cr
Net blockRs 0 Cr
Other liabilitiesRs 0 Cr
Shares outstanding (crore)1.08
Ownership
Promoter holding5.87% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.

Red flags

F-score 5 of 6
seriousNegative equity Shareholders' equity is negative
lookRepeated losses Net loss in each of the last two years
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Dec 2017
Sales ₹0 Cr. Net profit ₹0 Cr.

Activity

Compare
No listed peers in this industry.
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Standard Medical & Pharmaceuticals Ltd?

Standard Medical & Pharmaceuticals Ltd (511042) has a market capitalisation of Rs Cr. at the close.

What were Standard Medical & Pharmaceuticals Ltd's latest quarterly results?

In the Dec 2017 quarter, Standard Medical & Pharmaceuticals Ltd sales was Rs 0 Cr and net profit was Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03